In Vitro Inhibition of Rotavirus multiplication by Copper Oxide Nanoparticles

References
1. Arowolo, K.O., et al., Epidemiology of enteric viruses in
children with gastroenteritis in Ogun State, Nigeria.
Journal of medical virology, 2019. 91(6): p. 1022-1029.
2. Yang, H., et al., The distinct impact of maternal antibodies
on the immunogenicity of live and recombinant rotavirus
vaccines. Vaccine, 2019. 37(30): p. 4061-4067.
3. Guarino, A., et al., European Society for Pediatric
Gastroenterology, Hepatology, and Nutrition/European
Society for Pediatric Infectious Diseases evidence-based
guidelines for the management of acute gastroenteritis in
children in Europe: update 2014. Journal of pediatric
gastroenterology and nutrition, 2014. 59(1): p. 132-152.
4. Honda, M., et al., Liposomes and nanotechnology in drug
development: focus on ocular targets. International journal
of nanomedicine, 2013: p. 495-504.
5. Gwinn, M.R. and V. Vallyathan, Nanoparticles: health
effects—pros and cons. Environmental health perspectives,
2006. 114(12): p. 1818-1825.
6. Mukherjee, S. and C.R. Patra, Biologically synthesized
metal nanoparticles: recent advancement and future
perspectives in cancer theranostics. 2017, Future Science.
p. FSO203.
7. Ghosh, S. and A. Ghosh, Next-generation optical
nanotweezers for dynamic manipulation: from surface to
bulk. Langmuir, 2020. 36(21): p. 5691-5708.
8. Jain, N., et al., Removal of protein capping enhances the
antibacterial efficiency of biosynthesized silver
nanoparticles. PLoS One, 2015. 10(7): p. e0134337.
9. Akhtar, M.J., et al., Dose-dependent genotoxicity of copper
oxide nanoparticles stimulated by reactive oxygen species
in human lung epithelial cells. Toxicology and industrial
health, 2016. 32(5): p. 809-821.
10. Hang, X., et al., Antiviral activity of cuprous oxide
nanoparticles against Hepatitis C Virus in vitro. Journal of
virological methods, 2015. 222: p. 150-157.
11. Tavakoli, A. and M.S. Hashemzadeh, Inhibition of herpes
simplex virus type 1 by copper oxide nanoparticles. Journal
of virological methods, 2020. 275: p. 113688.
12. Fujimori, Y., et al., Novel antiviral characteristics of
nanosized copper (I) iodide particles showing inactivation
activity against 2009 pandemic H1N1 influenza virus.
Applied and Environmental Microbiology, 2012. 78(4): p.
951-955.
13. Tortella, G., et al., Silver, copper and copper oxide
nanoparticles in the fight against human viruses: progress
and perspectives. Critical Reviews in Biotechnology, 2022.
42(3): p. 431-449.
14. Hosseini, Z., et al., The human cathelicidin LL-37, a
defensive peptide against rotavirus infection. International
Journal of Peptide Research and Therapeutics, 2020. 26: p.
911-919.
15. Vimbela, G.V., et al., Antibacterial properties and
toxicity from metallic nanomaterials. International journal
of nanomedicine, 2017. 12: p. 3941.
16. Chatterjee, A.K., R. Chakraborty, and T. Basu,
Mechanism of antibacterial activity of copper
nanoparticles. Nanotechnology, 2014. 25(13): p. 135101.
17. Warnes, S.L., E.N. Summersgill, and C.W. Keevil,
Inactivation of murine norovirus on a range of copper alloy
surfaces is accompanied by loss of capsid integrity.
Applied and Environmental Microbiology, 2015. 81(3): p.
1085-1091.
18. Warnes, S.L. and C.W. Keevil, Inactivation of norovirus
on dry copper alloy surfaces. PloS one, 2013. 8(9): p.
e75017.